The Europe Wound Debridement Market would witness market growth of 5.1% CAGR during the forecast period (2022-2028).
The prominent factor that is driving the growth of the market is the increase in diabetes incidences as well as the rise in wounds associated with diabetes. People who have diabetes have an increased risk of developing chronic wounds, necessitating debridement procedures. It is well-known that poor quality of life, life-threatening infections, and amputations are some of diabetic foot ulcers’ dangerous consequences.
In addition, diabetic wounds may heal slowly and become long-lasting, as they can also reoccur even after healing. Therefore, wound debridement procedures become extremely important and even lifesaving in the case of diabetic wounds. Consequently, with the rising diabetic population of the world, incidences of chronic wounds are further expected to increase.
According to recent publications by the International Diabetes Federation (IDF), the diabetic population in the world will grow to around 783 million by 2045 and 643 million in 2030 from the present figures of 537 million in 2021. The same report also stated that approximately 541 million adults in the world are at risk of acquiring type 2 diabetes.
According to the WHO, diabetes prevalence is rising in the region, with approximately 10 to 12 % of the population of the European Union’s Member States suffering from the disease. This increase in prevalence is in tandem with the growing trends of obesity and overweight, physical inactivity, socioeconomic disadvantage, and unhealthy diets. In addition to diabetes, these risk factors propel the development of noncommunicable diseases (NCDs) like chronic respiratory disease, cardiovascular diseases, and cancer.
The Germany market dominated the Europe Wound Debridement Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $401.9 million by 2028. The UK market is anticipated to grow at a CAGR of 4.2% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 5.9% during (2022 - 2028).
Based on Mode of Purchase, the market is segmented into Prescription, Over The Counter and Others. Based on Product, the market is segmented into Medical Gauzes, Gels, Surgical Devices, Ultrasonic Devices, Ointments & Creams and Others. Based on Method, the market is segmented into Surgical, Autolytic, Enzymatic, Mechanical and Others. Based on Wound Type, the market is segmented into Diabetic Foot Ulcers, Pressure Ulcers, Burn Wounds and Venous Leg Ulcers & Others. Based on End-use, the market is segmented into Hospitals, Homecare and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Wound Debridement Market will Hit $6.1 Billion by 2028, at a CAGR of 5.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include 3M Company, Coloplast Group, Medline Industries, Inc., Smith & Nephew PLC, Medtronic PLC, ConvaTec Group PLC, Integra LifeSciences Holdings Corporation (Derma Sciences, Inc.), Johnson & Johnson (Ethicon, Inc.), Baxter International, Inc., and Molnlycke Health Care AB.
By Mode of Purchase
By Product
By Method
By Wound Type
By End-use
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 